<DOC>
	<DOCNO>NCT02225678</DOCNO>
	<brief_summary>Can clinical test developed could help manage asthma symptom ?</brief_summary>
	<brief_title>Minimally Invasive Biomarker Asthma Disease Severity</brief_title>
	<detailed_description>Project goal : Develop point-of-service assay ass eosinophilic airway inflammation Proposal Specific Aims : 1 . To establish infrastructure test feasibility sputum collection clinical set minimally invasive patient sample process biomarker test 2 . To transform laboratory-based eosinophil peroxidase ( EPX ) ELISA detection assay clinic-friendly assessment require sophisticated laboratory equipment</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Asthma subject : Inclusion Provider diagnose asthma FeNO &gt; 50 ppb FEV1 &gt; 1.0 Liter Exclusion COPD history Bronchiectasis history Pregnant participant Normal subject : Inclusion Age match asthma subject Exclusion Any eosinophil disorder history Asthma history Rhinitis sinusitis history</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>healthy volunteer</keyword>
	<keyword>asthma</keyword>
	<keyword>sputum eosinophil</keyword>
</DOC>